John R. Wingard, M.D.

• Professor
• Department of Medicine
• University of Florida
• Director of Bone Marrow Transplant Program
• Department of Medicine
• University of Florida Shands Cancer Center
• Gainesville, Florida

As meiosis I proceeds antifungal rinse for laundry generic 100mg mycelex-g overnight delivery, homologous chromosomes align across the cellular equator to form a coupling that ensures proper chromosome segregation later in the division anti fungal shampoo order mycelex-g 100mg fast delivery. Moreover antifungal talcum purchase mycelex-g 100mg on line, during the time homologous chromosomes face each other across the equator antifungal treatment for toenails order mycelex-g australia, the maternal and paternal chromosomes of each homologous pair may exchange parts fungus gnats life cycle purchase mycelex-g 100mg visa, creating new combinations of alleles at different genes along the chromosomes anti fungal diet food list purchase mycelex-g once a day. Afterward, the two homologous chromosomes, each still consisting of two sister chromatids connected at their centromeres, are pulled to opposite poles of the spindle. As a result, it is homologous chromosomes (rather than sister chromatids as in mitosis) that segregate into different daughter cells at the conclusion of the first meiotic division. With this overview in mind, let us take a closer look at the specific events of meiosis I, remembering that we analyze a dynamic, flowing sequence of cellular events by breaking it down somewhat arbitrarily into the easily pictured, traditional phases. ProphaseI:Homologscondenseandpair, andcrossing-overoccurs Among the crucial events of prophase I are the condensation of chromatin, the pairing of homologous chromosomes, and the reciprocal exchange of genetic information between these paired homologs. These complicated processes can take many days, months, or even years to complete. For example, in the female germ cells of several species, including humans, meiosis is suspended at prophase I for many years until ovulation (as will be discussed further in Section 4. Each chromosome has already duplicated prior to prophase I (as in mitosis) and thus consists of two sister chromatids affixed at their centromeres. At this point, however, these sister chromatids are so tightly bound together that they are not yet visible as separate entities. Sister chromatid 1 + Sister chromatid 2 Homologous chromosomes Synaptonemal complex Sister chromatid 3 + Sister chromatid 4 Synaptonemal complex Recombination nodules (a) Leptotene: Threadlike chromosomes begin (b) Zygotene: Chromosomes are clearly to condense and thicken, becoming visible visible and begin pairing with homologous as discrete structures. Although the chromosomes along the synaptonemal chromosomes have duplicated, the sister complex to form a bivalent, or tetrad. Chiasmata (d) Diplotene: Bivalent pulls apart slightly, but homologous chromosomes remain connected due to recombination at crossover sites (chiasmata). Pachytene (from the Greek for thick or fat) begins at the completion of synapsis when homologous chromosomes are united along their length. Each synapsed chromosome pair is known as a bivalent (because it encompasses two chromosomes), or a tetrad (because it contains four chromatids). On one side of the bivalent is a maternally derived chromosome, on the other side a paternally derived one. Such an exchange is known as crossing-over; it results in the recombination of genetic material. As a result of crossing-over, chromatids may no longer be of purely maternal or paternal origin; however, no genetic information is gained or lost, so all chromatids retain their original size. The aligned homologous chromosomes of each bivalent nonetheless remain very tightly merged at intervals along their length called chiasmata (singular, chiasma), which represent the sites where crossing-over occurred. Diakinesis (from the Greek for double movement) is accompanied by further condensation of the chromatids. Nonsister chromatids that have undergone crossing-over remain closely associated at chiasmata. The end of diakinesis is analogous to the prometaphase of mitosis: the nuclear envelope breaks down, and the microtubules of the spindle apparatus begin to form. As a result, in chromosomes aligned at the metaphase plate, the kinetochores of maternally and paternally derived chromosomes are subject to pulling forces from opposite spindle poles, balanced by the physical connections between homologs at chiasmata. Note that in anaphase of the first meiotic division, the sister centromeres do not separate as they do in mitosis. Thus, from each homologous pair, one chromosome consisting of two sister chromatids joined at their centromeres segregates to each spindle pole. Recombination through crossing-over plays an important role in the proper segregation of homologous chromosomes during the first meiotic division. The chiasmata hold the homologs together and thus ensure that their kinetochores remain attached to opposite spindle poles throughout metaphase. When recombination does not occur within a bivalent, mistakes in hookup and conveyance may cause homologous chromosomes to move to the same pole, instead of segregating to opposite poles. In some organisms, however, proper segregation of nonrecombinant chromosomes nonetheless occurs through other pairing mechanisms. Investigators do not yet completely understand the nature of these processes, and they are currently evaluating several models to explain them. TelophaseI:Nuclearenvelopesre-form the telophase of the first meiotic division, or telophase I, takes place when nuclear membranes begin to form around the chromosomes that have moved to the poles. Because the number of chromosomes is reduced to one-half the normal diploid number, meiosis I is often called a reductional division. In most species, cytokinesis follows telophase I, with daughter nuclei becoming enclosed in separate daughter cells. The kinetochores of sister chromatids fuse, so that 108 Chapter 4 the Chromosome Theory of Inheritance meiotic division. Mistakes in Meiosis Produce Defective Gametes Segregational errors during either meiotic division can lead to aberrations, such as trisomies, in the next generation. If, for example, the homologs of a chromosome pair do not segregate during meiosis I (a mistake known as nondisjunction), they may travel together to the same pole and eventually become part of the same gamete. Such an error may at fertilization result in any one of a large variety of possible trisomies. Most autosomal trisomies in humans, as we already mentioned, are lethal in utero; one exception is trisomy 21, the genetic basis of Down syndrome. Like trisomy 21, extra sex chromosomes may also be viable but cause a variety of mental and physical abnormalities, such as those seen in Klinefelter syndrome (see Table 4. First, the number of chromosomes is one-half that in mitotic metaphase of the same species. Second, in most chromosomes, the two sister chromatids are no longer strictly identical because of the recombination through crossing-over that occurred during meiosis I. The sister chromatids still contain the same genes, but they may carry different combinations of alleles. First, because only chance governs which paternal or maternal homologs migrate to the two poles during the first meiotic division, different gametes carry a different mix of maternal and paternal chromosomes. The amount of potential variation generated by this random independent assortment increases with the number of chromosomes. In a human being, however, where n = 23, this mechanism alone could generate 223, or more than 8 million genetically different kinds of gametes. A second feature of meiosis, the reshuffling of genetic information through crossing-over during prophase I, ensures an even greater amount of genetic diversity in gametes. Of course, sexual reproduction adds yet another means of producing genetic diversity. At fertilization, any one of a vast number of genetically diverse sperm can fertilize an egg with its own distinctive genetic constitution. It is thus not very surprising that, with the exception of identical twins, the 6 billion people in the world are each genetically unique. The independent alignment of each pair of homologs ensures the independent assortment of genes carried on different chromosomes. Distinguish between the sex chromosome complements of human female and male germ-line cells at different stages of gametogenesis. D Mitosis and Meiosis: A Comparison Mitosis occurs in all types of eukaryotic cells (that is, cells with a membrane-bounded nucleus) and is a conservative mechanism that preserves the genetic status quo. Mitosis followed by cytokinesis produces growth by increasing the number of cells. It also promotes the continual replacement of roots, stems, and leaves in plants and the regeneration of blood cells, intestinal tissues, and skin in animals. Meiosis, on the other hand, occurs only in sexually reproducing organisms, in just a few specialized germ cells within the reproductive organs that produce haploid gametes. It is not a conservative mechanism; rather, the extensive combinatorial changes arising from meiosis are one source of the genetic variation that fuels evolution. In all sexually reproducing animals, the embryonic germ cells (collectively known as the germ line) undergo a series of mitotic divisions that yield a collection of specialized diploid cells, which subsequently divide by meiosis to produce haploid cells. As with other biological processes, many variations on this general pattern have been observed. In some species, the haploid cells resulting from meiosis are the gametes themselves, while in other species, those cells must undergo a specific plan of differentiation to fulfill that function. Moreover, in certain organisms, the four haploid products of a single meiosis do not all become gametes. Gamete formation, or gametogenesis, thus gives rise to haploid gametes marked not only by the events of meiosis per se but also by cellular events that precede and follow meiosis. Here we illustrate gametogenesis with a description of egg and sperm formation in humans. The details of gamete formation in several other organisms appear throughout the book in discussions of specific experimental studies. Occurs in somatic cells and germ-line precursor cells Haploid and diploid cells can undergo mitosis One round of division S G1 M G2 Interkinesis Gamete formation Homologous chromosomes do not pair. During prophase of meiosis I, homologous chromosomes pair (synapse) along their length. Homologous chromosomes (not sister chromatids) attach to spindle fibers from opposite poles during metaphase I. The centromeres of the sister chromatids remain tightly attached during meiosis I. None of these is identical to each other or to the original cell, because meiosis results in combinatorial change. Fetal ovaries contain about 500,000 primary oocytes arrested in the diplotene substage of meiosis I. Only one of the three cells produced by meiosis serves as the functional gamete, or ovum. Released secondary oocyte Oogenesis in Humans Produces One Ovum from Each Primary Oocyte the end product of egg formation in humans is a large, nutrient-rich ovum whose stored resources can sustain the early embryo. For each primary oocyte, meiosis I results in the formation of two daughter cells that differ in size, so this division is asymmetric. The larger of these cells, the secondary oocyte, receives over 95% of the cytoplasm. The two small polar bodies apparently serve no function and disintegrate, leaving one large haploid ovum as the functional gamete. Thus, only one of the three (or rarely, four) products of a single meiosis serves as a female gamete. By six months after conception, the fetal ovaries are fully formed and contain about half a million primary oocytes arrested in the diplotene substage of prophase I. These cells, with their homologous chromosomes locked in synapsis, were thought for decades to be the only oocytes the female will produce. Scientists have shown that germ-line precursor cells removed from adult ovaries can produce new eggs in a petri dish. However, it is not yet known whether these eggs are viable nor if these germ-line cells normally produce eggs in adults. The nuclear membranes of the sperm and ovum dissolve, allowing their chromosomes to form the single diploid nucleus of the zygote, and the zygote divides by mitosis to produce a functional embryo. In contrast, unfertilized oocytes exit the body during the menses stage of the menstrual cycle. The long interval before completion of meiosis in oocytes released by women in their 30s, 40s, and 50s may contribute to the observed correlation between maternal age and meiotic segregational errors, including those that produce trisomies. During the later childbearing years, however, the risk rises rapidly; at age 35, it is 0. Spermatogonia are located near the exterior of seminiferous tubules in a human testis. Once they divide to produce the primary spermatocytes, the subsequent stages of spermatogenesis- meiotic divisions in the spermatocytes and maturation of spermatids into sperm-occur successively closer to the middle of the tubule. At the conclusion of meiosis, each original primary spermatocyte thus yields four equivalent haploid spermatids. These spermatids then mature by developing a characteristic whiplike tail and by concentrating all their chromosomal material in a head, thereby becoming functional sperm. Within each testis after puberty, millions of sperm are always in production, and a single ejaculate can contain up to 300 million. Spermatogenesis begins at puberty and continues through the lifetimes of human males. The two meiotic divisions of spermatogenesis are symmetrical, so a primary spermatocyte results in four sperm. We have presented thus far two circumstantial lines of evidence in support of the chromosome theory of inheritance. First, the phenotype of sexual morphology is associated with the inheritance of particular chromosomes. Second, the events of mitosis, meiosis, and gametogenesis ensure a constant number of chromosomes in the somatic cells of all members of a species over time; one would expect the genetic material to exhibit this kind of stability even in organisms with very different modes of reproduction. Final acceptance of the chromosome theory depended on researchers going beyond the circumstantial evidence to a rigorous demonstration of two key points: (1) that the inheritance of genes corresponds with the inheritance of chromosomes in every detail, and (2) that the transmission of particular chromosomes coincides with the transmission of specific traits other than sex determination. In a 1902 paper, Sutton speculated that "the association of paternal and maternal chromosomes in pairs and their subsequent separation during the reducing division (that is, meiosis I). Every cell contains two copies of each kind of chromosome, and two copies of each kind of gene. During meiosis, homologous chromosomes pair and then separate to different gametes, just as the alternative alleles of each gene segregate to different gametes. Maternal and paternal copies of each chromosome pair move to opposite spindle poles without regard to the assortment of any other homologous chromosome pair, just as the alternative alleles of unrelated genes assort independently. In all cells derived from the fertilized egg, one-half of the chromosomes and one-half of the genes are of maternal origin, the other half of paternal origin. The pairing between the two homologous chromosomes during prophase through metaphase of meiosis I makes sure that the homologs will separate to opposite spindle poles during anaphase I. Thus, the separation of homologous chromosomes at meiosis I corresponds to the segregation of alleles. A second pair of homologous chromosomes carries the gene for seed color (alleles Y and y).

As it turned out quercetin antifungal activity discount mycelex-g 100 mg fast delivery, however fungus versus yeast cheap 100 mg mycelex-g amex, the ex periments described later in this chapter did indeed demonstrate that groups of three nucleotides represent all 20 amino acids fungus shroud armor purchase mycelex-g 100mg otc. Each codon fungus gnats morgellons generic mycelex-g 100 mg overnight delivery, designated by the bases defining its three nu cleotides antifungal supplements order mycelex-g online pills, specifies one amino acid fungal infection cheap mycelex-g 100mg free shipping. If you knew the sequence of nucleotides in a gene or its transcript as well as the sequence of amino acids in the cor responding polypeptide, you could then deduce the genetic code without understanding how the underlying cellular machinery actually works. Although techniques for deter mining both nucleotide and amino acid sequence are availa ble today, this was not true when researchers were trying to crack the genetic code in the 1950s and 1960s. In this way, they were able to use the abnormal (specific mutations) to understand the normal (the general relationship between genes and polypeptides). Even so, if unfolded and stretched out from N terminus to C terminus, proteins have a onedimensional, linear structure-a specific primary sequence of amino acids. In the 1960s, Charles Yanofsky was the first to compare maps of mutations within a gene to the particular amino acid substitutions that resulted. Yanofsky then puri fied and determined the amino acid sequences of the mutant tryptophan synthase subunits. By carefully analyzing his results, Yanofsky deduced two other key features of the relationship between nucleotides and amino acids. In another example, muta tion 78 changed the glycine at position 234 to cysteine (Cys), while mutation 58 produced aspartic acid (Asp) at the same position. These are all missense mutations that change a codon for one amino acid into a codon that speci fies a different amino acid. Because the smallest unit of recombination is the base pair, two mutations capable of recombination-in this case, in the same codon because they affect the same amino acid-must be in different (although nearby) nucleotides. Evidence that a codon is composed of more than one nucleotide Yanofsky observed that point mutations altering different nucleotide pairs may affect the same amino acid. When two mutant strains with different amino acids at the same position were crossed, recombination could produce a wild-type allele. Genetic map for trpA mutation Position of altered amino acid in TrpA polypeptide N 1 Amino acid in wild-type polypeptide Amino acid in mutant polypeptide (mutant number) (b) Recombination within a codon 0. Because point mutations that change only a single nucleotide pair affect only a single amino acid in a polypeptide, each nucleotide in a gene must influence the identity of only a single amino acid. In contrast, if a nucle otide were part of more than one codon, a mutation in that nucleotide would affect more than one amino acid. Nonoverlapping Triplet Codons Are Set in a Reading Frame Although the most efficient code to specify 20 amino ac ids requires three nucleotides per codon, more compli cated scenarios are possible. Surprisingly, genes with proflavininduced mutations did not revert to wildtype upon treatment with other muta gens known to cause nucleotide substitutions. Only further exposure to proflavin caused proflavininduced mutations to revert to wildtype. Crick and Brenner had to explain this observation before they could proceed with their phage ex periments. With keen insight, they correctly guessed that proflavin does not cause base substitutions; instead, it causes insertions or deletions of a single base pair. This hypothesis explained why basesubstituting mutagens could not cause reversion of proflavininduced mutations. Crick and Brenner supposed not only that each codon is a trio of nucleotides, but that each gene has a single start ing point. Changes that alter the grouping of nucleotides into codons are called frameshift mutations; they shift the reading frame for all codons beyond the point of insertion or deletion, almost always abolishing the function of the polypeptide product. Note that the gene would regain its wildtype activity only if the portion of the polypeptide encoded between the two mutations of op posite sign is not required for protein function, because in the double mutant, this region would have an improper amino acid sequence. Also, the incorrect amino acids must not prevent the protein from folding into a functional conformation. Crick and Brenner reasoned that if the first mutation was the addition of a single base pair, represented by the symbol (+), then the counteracting mutation must be the deletion of a base pair, represented as (-). If the frameshifted part of the gene instead encodes instructions to stop protein syn thesis by introducing a triplet that does not correspond to any amino acid, then production of a functional polypep tide will not be possible. The reason is that polypeptide synthesis would stop before the compensating mutation could reestablish the correct reading frame. The fact that intragenic suppression occurs as often as it does suggests that the code includes more than one codon for some amino acids. Recall that there are 20 common amino acids but 43 = 64 different combinations of three nucleotides. If each amino acid corresponded to only a sin gle codon, there would be 64 - 20 = 44 possible triplets not encoding an amino acid. These noncoding triplets would act as stop signals and prevent further polypeptide synthesis. However, we have seen that many frameshift mutations of one sign can be offset by mutations of the other sign. The distances between these mutations, estimated by recombination frequencies, are in some cases large enough to code for more than 50 amino acids, which would be possible only if most of the 64 possible triplet codons specified amino acids. Although the genetic experiments just described allowed remarkably prescient insights about the nature of the ge netic code, they did not establish a correspondence between specific codons and specific amino acids. Polypeptides with repeating units of four amino acids Tyr-Leu-Ser-Ile-Tyr-Leu-Ser-Ile. Sydney Brenner helped establish the identities of the stop codons in an alternative way, through ingenious experiments involving point mutations in a T4 phage gene named m, encoding a protein component of the phage head capsule. Such a mutation is called a nonsense mutation because it changes a codon that signifies an amino acid (a sense codon) into one that does not (a nonsense codon). It makes sense that the M protein encoded by m6, for example, is shorter than that encoded by m5 because the m6 nonsense mutation is closer to the beginning of the reading frame than m5. The historical basis of this nomenclature is the last name of one of the early investigators-Bernstein-which means amber in German; ochre and opal derive from their similarity with amber as semiprecious materials. The Genetic Code: A Summary the genetic code is a complete, unabridged dictionary equating the four-letter language of the nucleic acids with the 20-letter language of the proteins. The code is degenerate, meaning that more than one codon may specify the same amino acid. The code is nevertheless unambiguous because each codon specifies only one amino acid. Mutations may modify the message encoded in a sequence of nucleotides in three ways. Frameshift mutations are nucleotide insertions or deletions that alter the genetic instructions for polypeptide construction by changing the reading frame. Missense mutations change a codon for one amino acid to a codon for a different amino acid. The most likely explanation for the revertants was that their tryptophan synthase gene carried both a single-base-pair deletion and a single-base-pair insertion (- +). His interpretations make sense only if codons do not overlap and are read from a fixed starting point, with no pauses or commas separating the adjacent triplets. A logical question thus arose: Do living cells construct polypeptides according to the same rules Early evidence that they do came from studies analyzing how mutations actually affect the amino acid composition of the polypeptides encoded by a gene. As a result, most missense mutations that change the identity of a single amino acid should be single-nucleotide substitutions, and analyses of these substitutions should conform to the code. Even more informative were the trpA+ revertants of these mutations subsequently isolated by Yanofsky. Note that some of these substitutions restore Gly to position 211 of the polypeptide, while others place amino acids such as Ile, Thr, Ser, Ala, or Val at this site in the tryptophan synthase molecule. Subsequent treatment of these mutants with more proflavin generated some substitutions caused by trpA- mutations and trpA+ reversions. This question is our focus as we present in the next sections the details of transcription and translation. Conservation of the genetic code the universality of the code is an indication that it evolved very early in the history of life. Once it emerged, the code remained constant over billions of years, in part because evolving organisms would have little tolerance for change. Exceptional genetic codes Researchers were thus quite amazed to observe a few exceptions to the universality of the code. Each mitochondrion has its own chromosomes and its own apparatus for gene expression (which we describe in detail in Chapter 15). The most common nucleotides in these short regions constitute the consensus sequences shown. A key difference with prokaryotes is that sequences called enhancers that can be thousands of base pairs away from the pro moter are often also required for efficient transcription of eukaryotic genes. Chapters 16 and 17 will describe how prokaryotic and eukaryotic cells can exploit these and other variations to control when, where, and at what level a given gene is ex pressed. As we see in the following section, this processing has played a fundamental role in the evolution of complex organisms. Hydrolysis of the highenergy bonds in each ribonu cleotide triphosphate provides the energy needed for elongation. The enzyme identifies the template strand and chooses the two nucleotides to be copied. These changes enable the core enzyme to leave the promoter yet remain bound to the gene. If, by contrast, you started at point B and moved in the opposite direction to point A, you would be traveling upstream. The double helixes then travel to the nucleus where another enzyme, called integrase, inserts them into a host chromosome. Once integrated into a host-cell chromosome, the viral genome can do one of two things. Reverse transcriptase, however, introduces one mutation in every 5000 incorporated nucleotides. As long as the immune system is strong enough to withstand the assault, it responds by producing as many as 2 billion new cells daily. Many of these new immune system cells produce antibodies targeted against proteins on the surface of the virus. But just when an immune response wipes out those viral particles carrying the targeted protein, virions incorporating new forms of the protein resistant to the current immune response make their appearance. However, the drugs are toxic at high doses and thus can be administered only at low doses that do not destroy all virions. Newer drugs added to the cocktail include protease inhibitors that prevent the activity of enzymes needed to produce viral coat proteins, drugs that prevent viral entry into human cells, and inhibitors of the viral integrase protein. Researchers are studying what happens when the virus increases its mutational load. If geneticists could figure out how to make this happen, they might be able to give the human immune system the advantage it needs to overcome the virus. Capping enzyme connects a backward G to the first nucleotide of the primary transcript through a triphosphate linkage. Other genes in humans generally have many fewer introns, while a few have none-and the introns range from 50 bp to over 100 kb. Introns can interrupt a gene at any location, even be tween the nucleotides making up a single codon. In such a case, the three nucleotides of the codon are present in two different (but successive) exons. Three types of short sequences within the primary transcript-splice donors, splice acceptors, and branch sites-help ensure the specificity of splicing. These sites make it possible to sever the con nections between an intron and the exons that precede and follow it, and then to join the formerly distant exons. The second cut is at the spliceacceptor site, at the 3 end of the intron; this cut removes the intron. Exons are shown in red, introns in green, and nontranscribed parts of the gene in blue. Given the complexities of spliceosome structure, it is remarkable that a few primary transcripts can splice them selves without the aid of a spliceosome or any additional factor. One hypothesis proposes that introns make it possible to assemble genes from various exon building blocks that encode modules of protein function. This type of assembly would allow the shuffling of exons to make new genes, a process that appears to have played a key role in the evolution of com plex organisms. The exonasmodule proposal is attrac tive because it is easy to understand the selective advantage of the potential for exon shuffling. Neverthe less, it remains a hypothesis without proof; introns may have become established through means that scientists have yet to imagine. As an example, splicing may occur between the splice donor site of one intron and the splice acceptor site of a different intron downstream. In effect then, alternative splicing can tailor the nucleotide sequence of a primary transcript to produce more than one kind of polypeptide. Alternative splicing largely explains how the 27,000 genes in the human genome can encode the hundreds of thousands of different proteins estimated to exist in human cells. In mammals, alternative splicing of the gene encoding the antibody heavy chain determines whether the antibody proteins become embedded in the membrane of the B lym phocyte that makes them or are instead secreted into the blood. The gene for antibody heavy chains has eight exons and seven introns; exon number 6 has a splicedonor site within it. Describe the key steps of translation, indicating how each depends on the ribosome. List three categories of posttranslational processing and provide examples of each. Folding in threedimensional space creates a tertiary structure that looks like a compact letter L.

Rearrangements and changes in chromosome number may affect gene activity or gene transmission by altering the position fungus pedicure discount mycelex-g 100mg line, order antifungal alcohol buy mycelex-g 100mg free shipping, or number of genes in a cell antifungal cream for diaper rash buy cheap mycelex-g on line. Such alterations often antifungal cream for yeast infection buy mycelex-g 100 mg visa, but not always fungus gnats eating seeds order mycelex-g online from canada, lead to a genetic imbalance that is harmful to the organism or its progeny fungus gnats pupa order mycelex-g no prescription. First, karyotypes generally remain constant within a species, not because rearrangements and changes in chromosome number occur infrequently (they are, in fact, quite common), but because the genetic instabilities and imbalances produced by such changes usually place individual cells or organisms and their progeny at a selective disadvantage. Second, despite selection against chromosomal variations, related species almost always have different karyotypes, with closely related species (such as chimpanzees and humans) diverging by only a few rearrangements and more distantly related species (such as mice and humans) diverging by a larger number of rearrangements. These observations suggest that significant correlation exists between karyotypic rearrangements and the evolution of new species. Some do so by removing or adding base pairs (deletions and duplications of particular chromosomal regions, respectively). Others relocate chromosomal regions without changing the number of base pairs they contain (inversions, which are half-circle rotations of a chromosomal region; and reciprocal translocations, in which two nonhomologous chromosomes exchange parts). This article focuses on heritable rearrangements that can be transmitted through the germ line from one generation to the next, but it also explains that the genomes of somatic cells can undergo changes in nucleotide number or order. In this section, we first explain how heritable chromosomal rearrangements come about and how scientists can track their presence. Finally, we illustrate how geneticists can exploit the existence of rearrangements as tools in genetics research. Rare, aberrant crossover events between repeated sequences on the same chromosome or on two different chromosomes can also generate rearrangments. A single genome may accumulate hundreds of thousands of copies of such an element. The green arrows represent the repeated sequences and indicate their relative orientations. It includes close to a trillion B lymphocytes, specialized white blood cells that make more than a billion different varieties of antibodies (also called immunoglobulins, or Igs). Each B cell, however, makes antibodies against only a single bacterial or viral protein (called an antigen in the context of the immune response). The binding of antibody to antigen helps the body attack and neutralize invading pathogens. The answer is that programmed gene rearrangements, in conjunction with somatic mutations and the diverse pairing of polypeptides of different sizes, can generate roughly a billion binding specificities from a much smaller number of genes. To understand the mechanism of this diversity, it is necessary to know how antibodies are constructed and how B cells come to express the antibodyencoding genes determining specific antigen-binding sites. Each light and each heavy chain has a constant (C) domain and a variable (V) domain. The C domain of the heavy chain determines whether the antibody falls into one of five major classes (designated IgM, IgG, IgE, IgD, and IgA), which influence where and how an antibody functions. For example, IgM antibodies form early in an immune response and are anchored in the B-cell membrane; IgG antibodies emerge later and are secreted into the blood serum. The C domains of the light and heavy chains are not involved in determining the specificity of antibodies. In all germ-line cells and in most somatic cells, including the cells destined to become B lymphocytes, these various gene segments lie far apart on the chromosome. During B-cell development, however, somatic rearrangements juxtapose random, individual V, D, and J segments together to form the particular variable region that will be transcribed. The somatic rearrangements that shuffle the V, D, J, and C segments at random in each B cell permit the expression of one, and only one, specific heavy chain. Random somatic rearrangements also generate the actual genes that will be expressed as light chains. The somatic rearrangements allowing the expression of antibodies thus generate enormous diversity of binding sites through the random selection and recombination of gene elements. The fact that any light chain can pair with the Genetics of Antibody Formation Produce Specificity and Diversity All antibody molecules consist of a single copy or multiple copies of the same basic molecular unit. Both heavy and light chains have variable (V) domains (yellow) near their N termini, which associate to form the antigenbinding site. N V any heavy chain increases exponentially the potential diversity of antibody types. For example, if there were 104 different light chains and 105 different heavy chains, there would be 109 possible combinations of the two. In carrying out their rearrangement activities, however, the enzymes sometimes make a mistake that results in a reciprocal translocation between human chromosomes 8 and 14. After this translocation, the enhancer of the chromosome 14 heavy-chain gene lies in the vicinity of the unrelated c-myc gene from chromosome 8. Under normal circumstances, c-myc generates a transcription factor that turns on other genes active in cell division, at the appropriate time and rate in the cell cycle. However, the translocated antibody-gene enhancer accelerates expression of c-myc, causing B cells containing the translocation to divide out of control. Thus, although programmed gene rearrangements are necessary for the normal development of a healthy immune system, misfiring of the rearrangement mechanism can promote disease. The photograph at the beginning of this chapter shows how multicolor banding reveals the presence and nature of a deletion in a human chromosome. The two reciprocally translocated chromosomes are stained both red and green (arrows). Two normal, nontranslocated chromosomes are stained entirely red or entirely green (arrowheads). Genome sequencing can reveal chromosomal rearrangements at the ultimate level of resolution: the nucleotide pair. The unusual sequences at these junctions will be found in certain reads from the whole genome sequence data. Knowledge of these breakpoints is crucial for understanding which genes could be responsible for a mutant phenotype associated with the rearrangement. For example, you will see later in this chapter that a type of leukemia (a white blood cell cancer) is caused by a certain reciprocal translocation. Amplification of a product specific for one of the translocation breakpoints would show that at least a few cancerous cells have survived, indicating the need for more treatment. Describe the phenotypic consequences of deletions in homozygotes and heterozygotes. Explain why the breakpoints of inversions determine whether they have phenotypic effects. Define reciprocal translocation and discuss when such rearrangements may have phenotypic consequences. Summarize the effects of inversions and translocations on crossing-over and fertility. The existence or severity of the effect usually depends on whether the individual is a homozygote or heterozygote for the rearranged chromosomes. In addition, these different types of changes to chromosomes can alter crossing-over as well as the fertility of individuals. Very large deletions that include many genes (such as the loss of half or more of a chromosome arm) are usually lethal even in heterozygotes because of the accumulated smaller effects of halving the dosage of many genes. Vulnerability to mutation Another reason why heterozygosity for a deletion can be harmful is that cells become vulnerable to mutations that inactivate the one remaining copy of a gene. Karyotypes of normal, noncancerous tissues from many people with retinoblastoma reveal heterozygosity for deletions of chromosome 13 that include the retinoblastoma gene. The retinoblastoma gene is only one of many tumor suppressor genes whose role in the generation of cancers will be discussed in depth in Chapter 20. Uncovering recessive mutant alleles A deletion heterozygote is, in effect, a hemizygote for genes on the normal, nondeleted chromosome that are missing from the deleted chromosome. If the normal chromosome carries a mutant recessive allele of one of these genes, the individual will exhibit the mutant phenotype. In Drosophila, for example, the scarlet (st) eye color mutation is recessive to wild type. However, an animal heterozygous for the st mutation and a deletion that removes the scarlet gene (st/Del) will have bright scarlet eyes, rather than wild-type, dark red eyes. We will use the symbol Del to designate a chromosome that has sustained a large deletion. In the following discussion, it will be helpful if you consider Del chromosomes as having amorphic (complete loss-of-function) alleles for the deleted genes. In rare cases where the deleted chromosomal region is devoid of genes essential for viability, however, a deletion hemi- or homozygote may survive. For example, Drosophila males hemizygous for an 80 kb deletion including the white (w) gene survive perfectly well in the laboratory; lacking the w+ allele required for red eye pigmentation, they have white eyes. Detrimental effects of heterozygosity for a deletion Usually, an organism can survive with a chromosome deleted for more than a few genes only if the homologous chromosome has normal copies of the missing genes. Even though all the genes are present in at least one copy, deletion heterozygotes can have mutant phenotypes for several reasons. Haploinsufficiency Deletion heterozygotes sometimes have a mutant phenotype due to haploinsufficiency; that is, half of the normal gene dosage (the number of times a given gene is present in the genome) does not produce enough protein product for a normal phenotype. In some cases, the abnormal phenotype is due to lowered dosage of a single gene within the deletion. Such effects of deletions are atypical because only about 800 genes in the human genome are haploinsufficient. However, lowered dosage of almost any gene Using deletions to locate genes Geneticists can use deletions to find genes associated with abnormal phenotypes. The basic requirement is the availability of a recessive loss-of-function mutation m (that is, an amorphic or hypomorphic allele) that causes the phenotype. If the phenotype of an m/Del heterozygote is mutant (like that of m/m), the deletion has uncovered the mutated locus; at least part of the gene thus lies inside the region of deletion. You can consider this experiment as a complementation test between the mutation and the deletion: the uncovering of a recessive mutant phenotype demonstrates a lack of complementation because neither chromosome can supply wild-type gene function. A fly with the genotype st/Del displays the recessive scarlet eye color because the Del chromosome lacks an st+ gene. The phenotypes of the five different deletion heterozygotes shown indicate that st+ is located between the vertical dotted lines. Effects of deletion heterozygosity on genetic map distances Because recombination between maternal and paternal homologs can occur only at regions of similarity, map distances derived from genetic recombination frequencies in deletion heterozygotes will be aberrant. During prophase of meiosis I, the undeleted region of the normal chromosome has nothing with which to pair and forms a deletion loop. In fact, during the pairing of homologs in prophase of meiosis I, the "orphaned" region of the nondeleted chromosome forms a deletion loop-an unpaired bulge of the normal chromosome that corresponds to the area deleted from the other homolog. As a result, these genes cannot be separated by recombination, and the map distances between them, as determined by the phenotypic classes in the progeny of a Del/+ individual, will be zero. In tandem duplications, the repeated copies lie adjacent to each other, either in the same order or in reverse order. In nontandem (or dispersed) duplications, the copies of the region are not adjacent to each other and may lie far apart on the same chromosome or on different chromosomes. In tandem duplications, the repeated regions lie adjacent to each other in the same or in reverse order. Deletion heterozygotes have only one copy of genes within the deletion, while duplication heterozygotes have three copies. Some duplications nevertheless do have phenotypic consequences for visible traits or for survival, and these abnormal phenotypes can occur for at least two reasons. First, certain phenotypes may be particularly sensitive to an increase in the number of copies of a particular gene or set of genes. Second, but more rarely, a gene near one of the borders of a duplication has altered expression because it is now found in a new chromosomal environment that does not exist in a wild-type chromosome. Organisms are not usually so sensitive to additional copies of a single gene; but just as for large deletions, imbalances for the many genes included in a large duplication have additive deleterious effects that jeopardize survival. In humans, a variety of disease syndromes are associated with heterozygosity for duplications of several megabases. Heterozygosity for even larger duplications (such as duplications of an entire chromosome arm) is most often lethal. Unequal crossing-over between duplications In individuals homozygous for a tandem duplication (Dp/Dp), homologs carrying the duplications occasionally pair out of register during meiosis. Unequal crossing-over, that is, recombination resulting from such out-of-register pairing, generates gametes containing increases to three and reciprocal decreases to one in the number of copies of the duplicated region. Drosophila females homozygous for the Bar eye duplication produce mostly Bar eye progeny. Unequal crossing-over in females homozygous for doubleBar chromosomes can yield progeny with even more extreme phenotypes associated with four or five copies of the duplicated region. Duplications in homozygotes thus allow for the expansion and contraction of the number of copies of a chromosomal region from one generation to the next. As a result, the Bar gene is transcribed at much higher than normal levels, leading to smaller eyes. When the rotated segment includes the centromere, the inversion is pericentric; when the rotated segment does not include the centromere, the inversion is paracentric. As you will see later in this section, the location of the centromere relative to the inversion influences how an inversion-bearing chromosome behaves during meiotic cell divisions. However, inversions can cause mutations in specific genes that span inversion breakpoints. The inversion breaks the gene into two parts, relocating one part to a distant region of the chromosome, while leaving the other part at its original site.

Order mycelex-g with amex. How Long Does It Take For A Fungal Infection To Clear Up?.

Explain how human mosaicism could complicate the process of pinpointing a recessive or dominant disease-causing mutation by positional cloning or by genome sequencing anti fungal soap in the philippines purchase generic mycelex-g canada. Some cells have differentiated into eyes fungus allergy cheap 100 mg mycelex-g fast delivery, others into whiskers fungus nose order mycelex-g 100mg fast delivery, yet others to skin antifungal ointment discount 100mg mycelex-g mastercard, and so on fungus yellow nails purchase mycelex-g 100 mg without a prescription. Some of the proteins on the chromosomes tell genes when to turn on and off antifungal internal generic 100 mg mycelex-g fast delivery, and are thus responsible for cell differentiation. In this article, we examine the structure and function of the eukaryotic chromosome. When viewed under the light microscope, chromosomes change shape, character, and position as they pass through the cell cycle. By metaphase of mitosis, they appear as paired bars (the two sister chromatids) in the middle of the spindle apparatus. Then, in succeeding sections of this chapter, we explain how these chromosomal components interact to produce the observed metamorphoses of structure. The repetitive sequences at these locations are crucial for several aspects of chromosome biology to be discussed in later sections of this chapter. Histone proteins Discovered in 1884, histones are relatively small proteins with a preponderance of the basic, positively charged amino acids lysine and arginine. Histones make up half of all chromatin protein by weight and are classified into five types of molecules: H1, H2A, H2B, H3, and H4. In the H4 proteins of pea plants and calves, for example, all but two of 102 amino acids in the polypeptide sequence are identical. That histones have changed so little throughout evolution underscores the importance of their contribution to chromatin structure. Nonhistone proteins the remaining half of the mass of protein in eukaryotic cell chromatin is not composed of histones. Rather, it consists of thousands of different kinds of nonhistone chromosomal proteins. The chromatin of a diploid genome contains from 200 to 2,000,000 molecules of each kind of nonhistone protein. Not surprisingly, this large variety of proteins fulfills many different functions. When this human chromosome was gently treated with detergents to remove the histones and some nonhistone proteins, a dark scaffold composed of the remaining nonhistone proteins became visible in the shape of the two sister chromatids. Some nonhistone proteins are required for chromosome movements along the spindle during cell division. Summarize the process of detecting G bands in a chromosome and how these bands are used in locating genes. By far the largest class of nonhistone proteins constitute those which foster or regulate transcription during gene expression. Additional levels of compaction, which researchers do not yet understand, produce the metaphase chromosomes observable in the microscope. Scientists can crystallize the nucleosome cores and subject the crystals to X-ray diffraction analysis. The nucleosomes of each chromosome are not evenly spaced, but they do have a particular arrangement along the chromatin. This arrangement varies among different cell types, and it can change even in a single cell when conditions are altered. This is still much too long to fit in the nucleus of even the largest cell, and additional compaction is required. Higher-Order Packaging Condenses Chromosomes Further Many of the details of chromosomal condensation beyond the nucleosome remain unknown, but researchers have proposed several models to explain the different levels of compaction (see Table 12. Thus, the loops and scaffold concept of higher-order chromatin packaging remains a hypothesis. The hypothetical status of this higher-order compaction model contrasts sharply with nucleosomes, which are entities that investigators have isolated, crystallized, and analyzed in detail. With this amount of compaction, the centromere region and telomeres of each chromosome become visible. We have also seen (in Chapter 4) that various staining techniques reveal a characteristic banding pattern, size, and shape for each metaphase chromosome, establishing a karyotype. Regardless of the underlying cause, every time a chromosome replicates, its banding pattern is faithfully reproduced. The reproducibility of this pattern means that geneticists can designate the chromosomal location of a gene by describing its position in relation to the bands on the p (short; after the French petit) or q (long; for queue, the French word for tail) arm of a particular chromosome. For this purpose, the p and q arms are subdivided into regions, and within each region, the dark and light bands are numbered consecutively. Genes for color blindness in humans are located in a small region near the tip of the long arm (q) of the X chromosome. Karyotypes show the G-banded chromosomes constituting the whole genome, but obviously at a resolution much lower than that of individual nucleotide pairs. In contrast, it is hard to step back from the mass of information derived from whole-genome sequencing to obtain a global view of genome organization. Researchers first obtain cells in mitotic metaphase and then drop the cells onto a glass microscope slide. This latter denaturation step is performed in a way that preserves the overall chromosomal structure, even though the double helixes separate into single strands at numerous points. The probe will hybridize only with chromosomal regions that are complementary in nucleotide sequence, and the researchers can identify these regions by looking in a fluorescence microscope. Historically, this method was of considerable importance in verifying that the original draft of the Human Genome Project was properly assembled. The yellow spots show where a probe made from a single gene hybridizes to the two sister chromatids on each of two homologous chromosomes. Because the two sister chromatids are extremely close together in this preparation, only one yellow spot appears on each homolog. The pattern of G bands is highly specific and reproducible, allowing identification of chromosomes and gene locations. Describe how scientists use position effect variegation to study the mechanisms underlying the formation of heterochromatin. Outline how histone methylation and acetylation affect chromatin structure and gene expression. How do these proteins access particular nucleotide sequences that appear to be buried within complex chromatin structures The answer is that chromatin structure is dynamic and can change to allow access of specific proteins when they need to act. These changes produce variations in chromatin structure necessary for different chromosomal functions. In this section we focus on the relationship between chromatin structure and gene transcription. We then discuss a type of chromatin structure called heterochromatin that is associated with chromosomal regions that are not transcribed. The formation of heterochromatin is the molecular basis for several important genetic phenomena, including X chromosome inactivation in mammals. Studies of chromatin structure show that the promoters of most inactive genes are indeed wrapped in nucleosomes. Nucleosome Histone core Promoter (b) Chromatin remodeling complexes can expose gene promoters. Other chromatin modulators chemically modify the tails of the histones in the nucleosome core (as will be explained later). As a result, differentiated cells have specific patterns of chromatin configuration and gene expression that persist after the cells divide by mitosis. Most Genes in Heterochromatin Regions Are Silenced One type of chromatin organization is widespread in genomes and is correlated with the strong suppression of gene expression. Geneticists call these darker regions heterochromatin; they refer to the contrasting lighter regions as euchromatin. The distinction between euchromatin and heterochromatin also appears in electron microscopy, where the heterochromatin appears much more condensed than the euchromatin. Microscopists first identified dark-staining heterochromatin in the decondensed chromatin of interphase cells, where it tends to localize at the periphery of the nucleus. Human metaphase chromosomes were stained using a special technique that darkens the constitutive heterochromatin, most of which is in regions surrounding the centromeres. In Drosophila, the entire Y chromosome, and in humans, most of the Y chromosome, is heterochromatic. Chromosomal regions that remain condensed in heterochromatin at most times in all cells are known as constitutive heterochromatin. This observation indicates that euchromatin contains most of the sites of transcription and thus almost all of the genes. We now discuss two specialized phenomena-positioneffect variegation in Drosophila and Barr bodies in mammalian females-that illustrate clearly the correlation between loss of gene activity and heterochromatin formation. These phenomena also helped scientists investigate the biochemical differences between heterochromatin and euchromatin. Heterochromatin Can Spread Along a Chromosome and Silence Nearby Euchromatic Genes the white+ (w+) gene in Drosophila is normally located near the telomere of the X chromosome, in a region of relatively decondensed euchromatin. The phenomenon of position-effect variegation thus reflects the existence of facultative heterochromatin: regions of chromosomes (or even whole chromosomes) that are heterochromatic in some cells and euchromatic in other cells of the same organism. Such variation suggests that the decision determining whether heterochromatin spreads to the w+ gene in a particular cell is the result of a random process. Because patches composed of many adjacent cells have the same color, the decision must be made early in the development of the eye. These descendants occupy a particular region of the eye, forming patches of red or white cells, respectively. Appearance active w + = red inactive w + = white active rst + = smooth inactive rst + = rough Interpretation Red smooth sectors rst + w+ Rearrangement brings w + and rst + close to heterochromatin near centromere. Scope of heterochromatin effects One interesting property revealed by position-effect variegation is that heterochromatin can spread over more than 1000 kb of previously euchromatic chromatin. In the latter patches, the heterochromatin inactivated both the w+ and the rst+ gene. Red-colored, rough-surfaced patches never form, which means that the heterochromatin does not skip over genes as it spreads linearly along the chromosome. If heterochromatin can spread, how is the boundary between heterochromatin and euchromatin normally formed By looking for changes in the amount of variegation, researchers have obtained mutations that alter its efficiency. Enhancement of variegation (eyes more white) reflects gene inactivation in a larger number of cells; suppression of variegation (eyes more red) reflects gene inactivation in fewer cells. Apparently, when normally euchromatic genes like w+ come into the vicinity of heterochromatin, the heterochromatin can spread into the euchromatic regions, shutting off gene expression in those cells where the heterochromatic invasion takes place. In this way, they discovered that some of the genes influencing heterochromatin formation encode proteins that localize selectively to the heterochromatin. As described in the next section, the identification of these proteins has provided important clues about the biochemical control of chromatin structure. The N-terminal tails of the core histone proteins extend outward from the nucleosome. Various amino acids in these tails are targets for modifications such as methylation and acetylation that can alter chromatin structure. Modification sites Heterochromatin and Euchromatin Have Different Histone Modifications Several interdependent mechanisms govern the distinction between active (or potentially active) euchromatin and silenced heterochromatin. We focus here on one of the most important of these mechanisms, involving covalent modifications of the histones in the nucleosomes. Discussion of the interactions of chromatin modifier proteins with the transcription factors that regulate gene expression will be deferred until Chapter 17. Such modifications of these histone tails can influence the packing of nucleosomes, and the modified tails can also serve as platforms to which chromatin modifier proteins can bind.

However antifungal body soap cheap mycelex-g 100 mg without a prescription, with osimertinib treatment acquired resistance occurs antifungal uv light discount mycelex-g 100mg otc, most commonly manifested by the appearance of a third mutation fungus za uke buy genuine mycelex-g online, C797S fungus in brain order 100mg mycelex-g with amex. The mutation of Cys797 to Ser797 prevents formation of the potency-conferring covalent bond of the inhibitor (Thress et al fungus gnats peat moss 100 mg mycelex-g. Most adverse effects occur within the first month of therapy and are manageable with medications fungal disease definition cheap mycelex-g 100 mg otc. Asymptomatic increases in liver transaminases may necessitate discontinuation of therapy. Respiratory compromise and interstitial lung disease, especially in patients with prior radiation, occurs in fewer than 2% of patients but may have a fatal outcome. The elimination t1/2 of afatinib is 37 h after repeat dosing in patients with cancer. Afatinib is a substrate of Pgp and coadministration of Pgp-modulating drugs can alter effective drug concentrations of afatinib. Extracellular binding of agonist ligands to transmembrane growth factor receptors causes receptor dimerization and activation of a C-terminal protein kinase that initiates intracellular signaling cascades that regulate gene expression and control cancer cell proliferation, apoptosis, metabolism, and metastasis. Crosstalk between cancer cells and the host stroma (including the vasculature and immune cells) is modulated through the release of angiogenic factors and the expression of immune checkpoint proteins. Cancer cell signaling can be altered through increased expression of receptors. Small-molecule inhibitors (in blue) are depicted adjacent to their intracellular target proteins. Proteins within red ellipses provide activating signals, those in green ellipses, inhibitory signals. Following intravenous administration, steady-state levels are achieved by the third weekly infusion. Following intravenous administration every 2 weeks, steady-state levels are achieved by the third infusion. Adverse effects of panitumumab are similar to those of cetuximab and include rash and dermatological toxicity, infusion reactions, pulmonary fibrosis, and electrolyte abnormalities. Acneiform rash in the majority of patients, pruritus, nail changes, headache, and less frequently diarrhea are the most common adverse reactions. Thus, baseline electrocardiogram and cardiac ejection fraction measurement should be obtained before initiating treatment with trastuzumab to rule out underlying heart disease. However, left ventricular dysfunction occurs in up to 20% of patients who receive a combination of doxorubicin and trastuzumab, reflecting the added cardiotoxicity of doxorubicin. In contrast, the risk of cardiac toxicity is greatly reduced with the recommended combination of trastuzumab with taxanes. Adverse Effects Cardiotoxicity is similar to that of trastuzumab, and combinations with cardiotoxic anthracyclines are not indicated (Slamon et al. On the other hand, the combination of pertuzumab and trastuzumab does not cause any increase in cardiac toxicity (Swain et al. Based on its mechanism of action, pertuzumab can cause fetal harm when administered to a pregnant woman, and this risk should be weighed against the potential benefit. It is used in combination with cytotoxic chemotherapeutics such as taxanes as initial treatment or as a single agent following relapse of disease after cytotoxic chemotherapy (Chapter 66). Therapeutic Uses; Adverse Effects Adverse Effects and Precautions Acute adverse effects after infusion of trastuzumab are typical for monoclonal antibodies and can include fever, chills, nausea, dyspnea, and rashes. Frequent adverse effects include acneiform rash, diarrhea, cramping, and exacerbation of gastroesophageal reflux. Diarrhea was the most common and frequent adverse effect, with grade 3 or 4 in over one-third of patients (Park et al. Vismodegib can cause embryo-fetal death and severe birth defects and must not be used during pregnancy. These oncogenes were found to be mutated and constitutively active in approximately 20% of all cancers and in up to 90% in specific cancers (pancreatic adenocarcinoma). Adverse Effects the most common (20%) adverse effects of treatment with olaratumab are nausea, fatigue, neutropenia, musculoskeletal pain, inflammation of the mucous membranes (mucositis), alopecia, vomiting, diarrhea, decreased appetite, abdominal pain, neuropathy, and headache. Other adverse effects include infusion-related reactions (low blood pressure, fever, chills, rashes) and embryo-fetal harm. The hedgehog pathway controls embryonic cell differentiation in tissues of different species through distinct gradients of hedgehog signaling proteins that are key regulators during development. In adults, hedgehog signaling plays roles in stem cell regulation and tissue regeneration. Thus, concomitant use with the centrally acting 2 adrenergic receptor agonist tizanidine, which has a narrow therapeutic window and is used as a muscle relaxant, should be avoided. About one-third of those patients develop more than one lesion with continued administration of dabrafenib. Most common adverse reactions (20%) for dabrafenib in combination with trametinib are pyrexia, rash, chills, headache, arthralgia, and cough. Mechanism of Action Drug Resistance Melanoma is one of the most aggressive malignancies, with a high mutation rate that renders these tumors highly heterogeneous and thus prone to the quick development of resistance to drug treatments. After the initial response of melanoma lesions to treatment with vemurafenib, resistant cancer cell subpopulations are selected, typically in less than 6 months. Adverse Effects the most frequent adverse effects are cutaneous rash, acneiform dermatitis, and diarrhea. Other serious adverse effects are cardiomyopathy, hypertension, hemorrhage, interstitial lung disease, and ocular toxic effects. Because trametinib can cause fetal harm when administered to a pregnant woman, this risk must be weighed against the potential benefit. Resistance to single-agent trame- tinib occurs within 6 to 7 months of the initiation of treatment at a rate approaching 50%. The most common adverse reactions, thrombocytopenia and anemia, should be met with a dose reduction or discontinuation of treatment. Due to the adverse hematopoietic effects, postpartum patients should discontinue nursing during drug treatment. Adverse Effects the most common adverse effects are diarrhea, photosensitivity reaction, nausea, pyrexia, and vomiting. Major hemorrhagic events can occur with cobimetinib; patients should be monitored for signs and symptoms of bleeding. Jak signaling is dysregulated in myelofibrosis and polycythemia vera, which prompted the development of Jak inhibitors. Therapeutic Uses Ruxolitinib is indicated for the treatment of patients with polycythemia vera who have had an inadequate response to hydroxyurea and for the treatment of myelofibrosis. Hyperphosphorylation of Rb can occur via mutations in Rb or expression of viral oncoproteins targeting Rb, placing the cell in a state of extensive proliferation, with reduced capacity to exit the cell cycle. Palbociclib is used in combination with letrozole, an aromatase inhibitor, as initial endocrine-based therapy in postmenopausal women or with the antiestrogen fulvestrant in women with disease progression after endocrine-based therapy. The inclusion of palbociclib with different endocrine-based treatments almost doubles the progression-free survival of patients (Cristofanilli et al. Adverse Effects and Drug Interactions Adverse Effects and Drug Interactions the most common adverse effects of palbociclib are neutropenia, leukopenia, infections, stomatitis, fatigue, nausea, anemia, headache, diarrhea, and thrombocytopenia. The most common grades 3 and 4 adverse effects are neutropenia (>60%), leukopenia (~25%), and anemia (~5%). Thus, avoid concomitant use of phenytoin, rifampin, carbamazepine, enzalutamide, and St. The most common adverse effect (20%) in patients with B-cell malignancies are neutropenia, pyrexia, thrombocytopenia, hemorrhage, anemia, diarrhea, nausea, musculoskeletal pain, rash, and fatigue. The onset of hypertension has been observed within less than a month and up to 2 years after the start of ibrutinib treatment. Thus, blood pressure should be monitored and antihypertensive treatment initiated or modified. Atrial fibrillations are observed in up to 7% of patients; this requires monitoring and treatment. Second primary malignancies occur in up to 16% of patients, most of them nonmelanoma skin cancers. Ibrutinib is classified pregnancy category D (see Appendix I) and may cause fetal harm. These inhibitors are currently undergoing clinical trials in patients with breast cancer as well as a variety of other cancers. Metabolites are Imatinib, Dasatinib, and Nilotinib Mechanisms of Action these are orally bioavailable, small-molecule kinase inhibitors. Nilotinib was designed to have increased potency and specificity compared to imatinib. Approximately 30% of an oral dose of nilotinib is absorbed after administration, with peak concentrations in plasma 3 h after dosing. The drug has a plasma t1/2 about 17 h, and plasma concentrations reach a steady state only after 8 days of daily dosing. The contact points between imatinib and the enzyme become sites of mutations in drug-resistant leukemic cells; these mutations prevent tight binding of the drug and lock the enzyme in its open configuration, in which it has access to substrate and is enzymatically active. Nilotinib retains inhibitory activity in the presence of most point mutations that confer resistance to imatinib. Other mutations affect the phosphate-binding region and the "activation loop" of the domain with varying degrees of associated resistance. Some mutations, such as those at amino acids 351 and 355, confer low levels of resistance to imatinib, possibly explaining the clinical response of some resistant tumors to dose escalation of imatinib. This finding indicates that drug-resistant cells arise through spontaneous mutation and expand under the selective pressure of drug exposure. Amplification of the wild-type kinase gene, leading to overexpression of the enzyme, has been identified in tumor samples from patients resistant to treatment. Myelosuppression occurs infrequently but may require transfusion support and dose reduction or discontinuation of the drug. Dasatinib may cause pleural effusions and pulmonary hypertension in a small subset of patients. Most nonhematological adverse reactions are self-limited and respond to dose adjustments. After the adverse reactions have resolved, the drug may be reinitiated and titrated back to effective doses. The most common adverse reactions (incidence greater than 20%) are diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, and fatigue. The elimination t1/2 of imatinib and its major active metabolite, the N-desmethyl derivative, are about 18 and 40 h, respectively. Oral dasatinib is well absorbed; its bioavailability is significantly reduced at neutral gastric pH. Drug solubility is pH dependent, with higher pH resulting in decreased solubility. Unmetabolized ponatinib is primarily excreted in the feces (87%), with a small portion (5%) in the urine. Adverse Effects Adverse Effects Arterial thrombosis and hepatotoxicity are major adverse effects; thus, appropriate precautions, dose reduction, monitoring, or discontinuation are recommended following arterial thrombotic or hepatotoxic events. Dose-limiting toxicities include elevated lipase or amylase levels and pancreatitis. The and isoforms are ubiquitously expressed, whereas the and isoforms are predominantly expressed in cells of hematopoietic origin. The different catalytic subunits have distinct roles in normal and malignant B-cell function. The typical dose of 250 mg twice daily is reduced to once daily in patients with severe renal impairment and a creatinine clearance below 30 mL/min. Hepatic impairment increases systemic exposure, putting patients at risk for toxicity. Therapeutic Uses Clinical Use Idelalisib is approved for the treatment of relapsed or refractory B-cell malignancies in patients who have received at least two prior systemic therapies. Adverse Effects Temsirolimus and everolimus are approved for treatment of patients with advanced renal cancer. Everolimus, as compared to placebo, prolongs survival in patients who had failed initial treatment with antiangiogenic drugs. Other common side effects include fever, chills, cough, pneumonia, fatigue, nausea, abdominal pain, rash, hyperglycemia, and elevated levels of triglycerides and liver enzymes. Breastfeeding during therapy is contraindicated because of the potential for adverse reactions in nursing infants. A few patients will develop leukopenia or thrombocytopenia, effects that are reversed if therapy is discontinued. Less common side effects include hyperglycemia, hypertriglyceridemia, and, rarely, pulmonary infiltrates and interstitial lung disease. Pulmonary infiltrates emerge in 8% of patients receiving everolimus and in a smaller percentage of those treated with temsirolimus. If symptoms such as cough or shortness of breath develop or radiological changes progress, the drug should be discontinued. Multikinase Inhibitors Selectivity of small-molecule protein kinase inhibitors for their targets is dependent on the similarity of the targeted site with sites in other kinases and the chemical composition of the inhibitor. The selectivity of inhibitors for a range of targets in the kinome is determined experimentally using assays with recombinant kinase proteins and in vivo using intact cells that express the kinases (Elkins et al. Inhibitors that target multiple kinase families within the clinically used dose range can be therapeutically efficacious and are discussed in the material that follows. In using drugs directed toward protein kinases, remember that the specificity of these agents is not absolute and that the inhibited kinases often serve important "normal" functions in the cell in addition to the pathologic functions being targeted.